Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product ...

Anti-allergy medicine, known as antihistamines, is often seen by experts as the most popular ... The benefits can be felt ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...